ESTEVE CDMO 追加 1750 万美元扩建伊利诺伊州 Morton Grove 工厂
ESTEVE CDMO adds $17.5m to Illinois expansion
ESTEVE CDMO 向其伊利诺伊州 Morton Grove 工厂追加投资 1750 万美元，用于扩大产能与防护能力，使该厂址公布的投资总额达到 3300 万美元。此次投资紧随今年早些时候宣布的 1550 万美元项目，将用于购置两台 500 加仑反应釜、提升早期开发实验室的防护能力并翻新仓库。该厂址涵盖工艺研发、分析与稳定性检测、cGMP 原料药生产及 CMC 支持。
Brian Attwood | October 6, 2026 | News story | Clinical trials supplies & documentation logistics, Logistics & Distribution, Manufacturing and Production, Warehousing & distribution | API manufacture, Corporate, Pharmacy, investment, laboratory, pharma production
ESTEVE CDMO is investing a further $17.5m to expand capacity and containment capabilities at its Morton Grove facility in Illinois, taking total announced investment at the site to $33m.
The latest investment, following a $15.5m programme announced earlier this year, will fund two new 500-gallon reactors, enhanced containment capabilities in early-stage development laboratories and a warehouse refurbishment.
The upgrades are intended to increase capacity for early-stage development and allow the site to support manufacturing programmes as they progress towards larger clinical and commercial requirements.
The Morton Grove facility combines process research and development, analytical and stability testing, current good manufacturing practice (cGMP) active pharmaceutical ingredient (API) manufacturing and chemistry, manufacturing and controls (CMC) support.
Andrea Oro, Managing Director US and Global Head of Commercial Operations and Strategy at ESTEVE CDMO, said the investment would support the site’s development as a centre for early-stage development and manufacturing in the US.
来源：Pharmafile · pharmafile.com